ConductScience.org, home

Library / Genes

CD38: CD38 molecule

1 protein, 522 patents, 5 drugs, 423 trials, 10,818 NIH grants and 30,311 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolCD38HGNC
NameCD38 moleculeHGNC
NCBI Gene ID952NCBI Gene
HGNC IDHGNC:1667HGNC
EnsemblENSG00000004468NCBI Gene
AliasesADPRC 1, ADPRC1, cADPR1NCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
P28907ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 130056Ensembl, GeneID, HGNCUniProt

Patents 522

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
WO 2026213510 A12026-10-089P28907Espacenet
WO 2026190347 A12026-09-1777P28907Espacenet
EP 4806920 A12026-09-1677P28907Espacenet
EP 4803153 A22026-09-091P28907Espacenet
JP 2026108782 A2026-06-301P28907Espacenet
EP 4759326 A22026-06-179P28907Espacenet
EP 4751778 A22026-06-031P28907Espacenet
JP 2026090318 A2026-06-021P28907Espacenet
US 12637519 B22026-05-261P28907Espacenet
JP 2026513656 A2026-04-3038P28907Espacenet

Drugs 5

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource
DARATUMUMABCHEMBL1743007Lymphocyte differentiation antigen CD38 inhibitorINHIBITORChEMBL
FELZARTAMABCHEMBL4594579Lymphocyte differentiation antigen CD38 inhibitorINHIBITORChEMBL
HUMAX-IL15CHEMBL2109468Lymphocyte differentiation antigen CD38 inhibitorINHIBITORChEMBL
ISATUXIMABCHEMBL3545131Lymphocyte differentiation antigen CD38 inhibitorINHIBITORChEMBL
MEZAGITAMABCHEMBL4297833Lymphocyte differentiation antigen CD38 binding agentBINDING AGENTChEMBL

Trials 423

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource
NCT07605416DARATUMUMABPHASE2ClinicalTrials.gov
NCT07601100ISATUXIMABPHASE1/PHASE2ClinicalTrials.gov
NCT07600151ISATUXIMABPHASE1/PHASE2ClinicalTrials.gov
NCT07585760ISATUXIMABPHASE2ClinicalTrials.gov
NCT07513129DARATUMUMABPHASE1ClinicalTrials.gov
NCT07485647DARATUMUMABPHASE2ClinicalTrials.gov
NCT07479979ISATUXIMABPHASE1/PHASE2ClinicalTrials.gov
NCT07477587DARATUMUMABPHASE1ClinicalTrials.gov
NCT07452198DARATUMUMABPHASE3ClinicalTrials.gov
NCT07428369DARATUMUMABPHASE2/PHASE3ClinicalTrials.gov

NIH grants 10818

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
P30CA016672Cancer Center Support Grant2342,025NIH's project files
P30CA008748Cancer Center Support Grant2232,025NIH's project files
P30AI027763UCSF-Bay Area Center for AIDS Research1152,025NIH's project files
P51OD011132Emory National Primate Research Center762,025NIH's project files
P30AI036219Rustbelt Center for AIDS Research (Case/UHC-Pitt CFAR)682,025NIH's project files
UM1AI068636Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections682,025NIH's project files
U19AI057229Understanding Influenza and SARS-CoV-2 vaccine responses, in vivo and in vitro592,025NIH's project files
P50CA186781Mayo Clinic Multiple Myeloma SPORE582,025NIH's project files
UM1AI068634Statistical and Data Management Center (SDMC), Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (ACTG)532,025NIH's project files
U19AI057266Vaccine and Infection Induced Immunity in the Young and Aged522,025NIH's project files

Papers 30311

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42826058PubTator, text miningPubMed
42826002PubTator, text miningPubMed
42825903PubTator, text miningPubMed
42822478PubTator, text miningPubMed
42819898PubTator, text miningPubMed
42814322PubTator, text miningPubMed
42813301PubTator, text miningPubMed
42812913PubTator, text miningPubMed
42811274PubTator, text miningPubMed
42809701PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license